Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Income from Continuing Operations: 2013-2025

Historic Income from Continuing Operations for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to -$68.0 million.

  • Ocular Therapeutix's Income from Continuing Operations fell 56.01% to -$68.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$247.3 million, marking a year-over-year decrease of 78.13%. This contributed to the annual value of -$165.1 million for FY2024, which is 83.96% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Income from Continuing Operations of -$68.0 million as of Q3 2025, which was down 1.14% from -$67.2 million recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Income from Continuing Operations peaked at -$19.5 million during Q1 2022, and registered a low of -$68.0 million during Q3 2025.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$40.8 million (2024), whereas its average is -$41.2 million.
  • Per our database at Business Quant, Ocular Therapeutix's Income from Continuing Operations grew by 10.95% in 2022 and then tumbled by 115.51% in 2024.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Income from Continuing Operations stood at -$19.7 million in 2021, then dropped by 5.38% to -$20.8 million in 2022, then fell by 9.42% to -$22.7 million in 2023, then plummeted by 115.51% to -$49.0 million in 2024, then slumped by 56.01% to -$68.0 million in 2025.
  • Its Income from Continuing Operations was -$68.0 million in Q3 2025, compared to -$67.2 million in Q2 2025 and -$63.1 million in Q1 2025.